The role of complement C3 deposition in ANCA-associated glomerulonephritis: a registry-based study of clinical, histopathological, and prognostic insights
Authors:
- Sami UzunSUSami Uzun
- Ebru Gok OguzEOEbru Gok Oguz
- Abdülmecit YıldızAYAbdülmecit Yıldız
- Ulver DericiUDUlver Derici
- Emre CankayaECEmre Cankaya
- Gulizar SahinGSGulizar Sahin
- Erhan TatarETErhan Tatar
- Garip ŞahinGŞGarip Şahin
- Mevlüt Tamer DinçerMDMevlüt Tamer Dinçer
- Necmi ErenNENecmi Eren
- Kenan TurgutalpKTKenan Turgutalp
- Taner BaştürkTBTaner Baştürk
Open Access
- 2 August 2025
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 26 (1) , 1-13
Abstract
ANCA-associated glomerulonephritis (ANCA-GN) is a leading cause of pauci-immune crescentic GN. Recent evidence indicates that complement activation, marked by C3 deposition in glomeruli, may contribute to more severe renal injury and influence renal outcomes. We aim to evaluate the clinical, histopathological, and prognostic implications of C3 deposition in ANCA-GN. We retrospectively analyzed 195 patients with biopsy-proven ANCA-GN from the Turkish Society of Nephrology Glomerular Diseases registry from 2002 to 2022. Patients were classified as C3-positive or C3-negative according to kidney biopsy immunofluorescence findings. Clinical characteristics, histopathologic lesion profiles, and follow-up outcomes (remission, relapse, and survival) were compared between the two groups. Of 195 patients, 54 (27.7%) had C3 deposition. The C3-negative group was more likely to exhibit PR3-ANCA positivity, whereas the C3-positive group was strongly associated with the presence of MPO-ANCAs (22.2% vs. 77.8%; p = 0.001). Compared with C3-negative patients, C3-positive patients had higher levels of proteinuria (2026 mg/day vs. 1790 mg/day; p = 0.049) and lower HDL levels (30 mg/dL vs. 37 mg/dL; p = 0.009). Fibrocellular crescents were more common in C3-positive patients than in C3-negative patients (p < 0.001). Immune complex deposits, including IgG (26.4% vs. 3.5%; p < 0.001), IgA (14.8% vs. 0.7%; p < 0.001), IgM (25.0% vs. 3.5%; p < 0.001), and C1q (13.7% vs. 0.8%; p < 0.001) were significantly greater in the C3-positive group. However, no significant difference was detected in overall survival (85.8% for C3-negative patients vs. 88.9% for C3-positive patients; p = 0.249). Similarly, the remission (62.1% vs. 59.4%; p = 0.786) and relapse rates (14.8% vs. 11.1%; p = 0.532) did not differ between the groups. In ANCA-GN, glomerular C3 deposition is associated with an MPO-ANCA serotype, greater proteinuria, and more severe renal histology (including immune-complex deposition and more fibrocellular crescents), indicating more pronounced complement activation and tissue injury. However, C3 deposition did not predict worse patient or renal survival in our cohort. Not applicable.Keywords
This publication has 30 references indexed in Scilit:
- Long-Term Renal Survival in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis With Complement C3 DepositionKidney International Reports, 2021
- Characterization of interstitial infiltrates in MPO and PR3 anti-neutrophil cytoplasmic antibody glomerulonephritisJournal Of Nephrology, 2021
- Measuring Circulating Complement Activation Products in Myeloperoxidase– and Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated VasculitisArthritis & Rheumatology, 2019
- Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody–Associated VasculitisArthritis & Rheumatology, 2019
- Development and validation of a renal risk score in ANCA-associated glomerulonephritisKidney International, 2018
- Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcomeJournal Of Nephrology, 2017
- A proposal for standardized grading of chronic changes in native kidney biopsy specimensKidney International, 2017
- Glomerular C3d as a novel prognostic marker for renal vasculitisHuman Pathology, 2016
- Association Between Lipid Levels and Major Adverse Cardiovascular Events in Rheumatoid Arthritis Compared to Non–Rheumatoid Arthritis PatientsArthritis & Rheumatology, 2015
- Complement Activation Is Involved in Renal Damage in Human Antineutrophil Cytoplasmic Autoantibody Associated Pauci-Immune VasculitisJournal of Clinical Immunology, 2008